Attention Deficit Disorder with Hyperactivity - Blood
Research News and Information

Saturday, November 21, 2009

Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health?

29 Sep 2009 Interest in the role of polyunsaturated fatty acids (PUFAs), particularly long-chain (LC) omega-3 (n-3) PUFAs, in mental health is increasing. This review investigates whether n-3 PUFA levels are abnormal in people with three prevalent mental health ... Read more...

Project DyAdd: Fatty acids in adult dyslexia, ADHD, and their comorbid combination.

9 Jun 2009 In project DyAdd, we compared the fatty acid (FA) profiles of serum phospholipids in adults with attention deficit hyperactivity disorder (ADHD) (n=26), dyslexia (n=36), their comorbid combination (n=9), and healthy controls (n=36). FA proportions ... Read more...

Project DyAdd: Fatty acids and cognition in adults with dyslexia, ADHD, or both.

21 May 2009 Both attention deficit hyperactivity disorder (ADHD) and dyslexia are suggested to co-occur with altered fatty acid (FA) metabolism, but it is unknown how FAs are associated with the cognitive domains that characterize these disorders. In the ... Read more...

Latest indexed articles for 'Attention Deficit Disorder with Hyperactivity - Blood'

These are the very latest articles for this heading:

• Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health? 29 Sep 2009
• Attention deficit hyperactivity disorder and blood lead levels in Chinese children. 29 Jun 2009
• Project DyAdd: Fatty acids in adult dyslexia, ADHD, and their comorbid combination. 9 Jun 2009
• Project DyAdd: Fatty acids and cognition in adults with dyslexia, ADHD, or both. 21 May 2009
• [Correlation between ABO blood type gene and attention-deficit hyperactivity disorder in children] 29 Apr 2009
• Altered anandamide degradation in attention-deficit/hyperactivity disorder. 26 Apr 2009
• Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder. 15 Feb 2009
• Toward the dimensionome: parsing reward-related processing in attention-deficit/hyperactivity disorder. 30 Dec 2008
• Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children's health and environment research (CHEER). 28 Nov 2008
• No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. 26 Oct 2008
• Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. 28 Aug 2008
• Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). 6 Aug 2008
• Oxidative imbalance in adult attention deficit/hyperactivity disorder. Jul 2008
• Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder. 30 May 2008
• Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? 30 May 2008
• [Drug-induced psychosis after intake of a modified--release formulation of methylphenidate] 25 May 2008
• The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy. 30 Mar 2008
• Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment. 30 Mar 2008
• Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients. 5 Mar 2008
• [Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations] 28 Feb 2008

See a longer list of these articles.

Technical information about 'Attention Deficit Disorder with Hyperactivity'

Definition: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV)

Descriptor UI: D001289

Alternative terms: Attention Deficit Disorder with Hyperactivity; Hyperkinetic Syndrome; Syndromes, Hyperkinetic; Attention Deficit Hyperactivity Disorder; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorders; Brain Dysfunction, Minimal; Dysfunction, Minimal Brain; Minimal Brain Dysfunction; Attention Deficit Disorder; Attention Deficit Disorders; Deficit Disorder, Attention; Deficit Disorders, Attention; Disorder, Attention Deficit; Disorders, Attention Deficit;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;

Tree Number: F03.550.150.150;

Online Note: use ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY to search HYPERKINETIC SYNDROME 1981-83 & MINIMAL BRAIN DYSFUNCTION 1969-80 (as Prov 1969-72)

History Note: 84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1969-80 (Prov 1969-72)

Technical Notes: not confined to children; do not confuse with HYPERKINESIS: note X refs under both; DF: ADDH or ADHD